STOCK TITAN

Centessa Pharmaceuticals Announces Presentation at the SVB Securities Global Biopharma Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Centessa Pharmaceuticals (Nasdaq: CNTA) announced that its management team will participate in a fireside chat at the SVB Securities Global Biopharma Conference on February 14, 2023, at 8:00 a.m. ET. The event will be accessible via webcast, along with an archived recording available on the investor relations section of Centessa's website. The company focuses on developing transformative medicines across various stages of development, aiming to change treatment paradigms and set new standards of care for patients.

Positive
  • None.
Negative
  • None.

BOSTON and LONDON, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company focused on discovering and developing medicines that are transformational for patients, today announced that members of its management team will participate in a fireside chat at the virtual SVB Securities Global Biopharma Conference on Tuesday, February 14, 2023 at 8:00 a.m. ET.

A webcast of the fireside chat, as well as an archived recording, will be available under the “Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/events-presentations.

About Centessa Pharmaceuticals
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications. We operate with the conviction that each one of our programs has the potential to change the current treatment paradigm and establish a new standard of care. For more information, visit www.centessa.com, which does not form part of this release.

Contact:

Kristen K. Sheppard, Esq.
SVP of Investor Relations
investors@centessa.com


FAQ

What event will Centessa Pharmaceuticals participate in February 2023?

Centessa Pharmaceuticals will participate in the SVB Securities Global Biopharma Conference on February 14, 2023.

What time is Centessa Pharmaceuticals' fireside chat scheduled for?

The fireside chat is scheduled for 8:00 a.m. ET on February 14, 2023.

Where can I watch the Centessa Pharmaceuticals fireside chat?

The fireside chat will be available via webcast on the Centessa Pharmaceuticals investor relations website.

What does Centessa Pharmaceuticals focus on?

Centessa Pharmaceuticals focuses on discovering and developing transformative medicines for patients.

Centessa Pharmaceuticals plc American Depositary Shares

NASDAQ:CNTA

CNTA Rankings

CNTA Latest News

CNTA Stock Data

2.30B
114.15M
1.32%
92.52%
1.85%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
ALTRINCHAM, CHESHIRE